PLoS ONE (Jan 2023)

A machine learning approach identifies distinct early-symptom cluster phenotypes which correlate with hospitalization, failure to return to activities, and prolonged COVID-19 symptoms.

  • Nusrat J Epsi,
  • John H Powers,
  • David A Lindholm,
  • Katrin Mende,
  • Allison Malloy,
  • Anuradha Ganesan,
  • Nikhil Huprikar,
  • Tahaniyat Lalani,
  • Alfred Smith,
  • Rupal M Mody,
  • Milissa U Jones,
  • Samantha E Bazan,
  • Rhonda E Colombo,
  • Christopher J Colombo,
  • Evan C Ewers,
  • Derek T Larson,
  • Catherine M Berjohn,
  • Carlos J Maldonado,
  • Paul W Blair,
  • Josh Chenoweth,
  • David L Saunders,
  • Jeffrey Livezey,
  • Ryan C Maves,
  • Margaret Sanchez Edwards,
  • Julia S Rozman,
  • Mark P Simons,
  • David R Tribble,
  • Brian K Agan,
  • Timothy H Burgess,
  • Simon D Pollett,
  • EPICC COVID-19 Cohort Study Group

DOI
https://doi.org/10.1371/journal.pone.0281272
Journal volume & issue
Vol. 18, no. 2
p. e0281272

Abstract

Read online

BackgroundAccurate COVID-19 prognosis is a critical aspect of acute and long-term clinical management. We identified discrete clusters of early stage-symptoms which may delineate groups with distinct disease severity phenotypes, including risk of developing long-term symptoms and associated inflammatory profiles.Methods1,273 SARS-CoV-2 positive U.S. Military Health System beneficiaries with quantitative symptom scores (FLU-PRO Plus) were included in this analysis. We employed machine-learning approaches to identify symptom clusters and compared risk of hospitalization, long-term symptoms, as well as peak CRP and IL-6 concentrations.ResultsWe identified three distinct clusters of participants based on their FLU-PRO Plus symptoms: cluster 1 ("Nasal cluster") is highly correlated with reporting runny/stuffy nose and sneezing, cluster 2 ("Sensory cluster") is highly correlated with loss of smell or taste, and cluster 3 ("Respiratory/Systemic cluster") is highly correlated with the respiratory (cough, trouble breathing, among others) and systemic (body aches, chills, among others) domain symptoms. Participants in the Respiratory/Systemic cluster were twice as likely as those in the Nasal cluster to have been hospitalized, and 1.5 times as likely to report that they had not returned-to-activities, which remained significant after controlling for confounding covariates (P ConclusionsWe identified early symptom profiles potentially associated with hospitalization, return-to-activities, long-term symptoms, and inflammatory profiles. These findings may assist in patient prognosis, including prediction of long COVID risk.